Quantcast
Last updated on April 19, 2014 at 5:20 EDT

Latest Hyderabad District Stories

2012-07-25 02:29:37

ALBANY, N.Y., July 25, 2012 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced it will issue second quarter financial results before the opening of the market on Wednesday, August 1, 2012. Following the release of its results, the company will host a conference call and simultaneous webcast at 10 a.m. ET. (Logo: http://photos.prnewswire.com/prnh/20120229/NY61160LOGO ) The conference call can be accessed by dialing 888-417-8462 (domestic calls) or 719-325-2450 (international calls) at...

2012-07-19 02:25:56

ALBANY, N.Y., July 19, 2012 /PRNewswire/ -- AMRI (NASDAQ: AMRI) announced today that its subsidiary, India Pvt. Ltd. has been recognized by Abbott Health Care Pvt. Ltd. for the reliable supply of generic medications for the period from April 2011 to March 2012. This is the second year in a row that AMRI received the Silver Shield award in the category of "Strategic Partner," which recognizes AMRI's attention to communication, business continuity, quality, flexible pricing and in-time...

2012-06-19 02:21:18

ALBANY, N.Y., June 19, 2012 /PRNewswire/ -- As part of a long-term strategic plan to further AMRI's discovery capabilities in India, AMRI (NASDAQ: AMRI), a leading global contract research and manufacturing organization, announced the hiring of two experts in medicinal and computational chemistry at its research center located in Hyderabad, India (HRC). Simultaneously, the company announced the completion of the relocation of custom library synthesis resources and capabilities to HRC from the...

2012-06-05 02:28:17

ALBANY, N.Y., June 5, 2012 /PRNewswire/ -- AMRI (NASDAQ: AMRI) announced today that its Burlington site was contracted by Cardium Therapeutics (NYSE MKT: CXM) and its subsidiary, Tissue Repair Company ("Cardium") to manufacture sterile pre-filled syringes in support of the U.S. introduction of Excellagen(®), a professional-use, formulated collagen-based product for the management of diabetic foot ulcers, pressure ulcers and other dermal wounds. AMRI's highly collaborative approach to...

2012-05-22 02:26:58

ALBANY, N.Y., May 22, 2012 /PRNewswire/ -- AMRI (NASDAQ: AMRI), a leading global contract research and manufacturing organization, announced today the appointment of Ian Shott as President of AMRI Europe, reporting to Thomas D'Ambra, Ph.D., chairman, president and CEO. In this newly created role, Mr. Shott will have responsibility for AMRI's business operations in Europe, including the company's site in Wales, United Kingdom, and work closely with AMRI's European-based business...

2012-05-02 02:28:01

ALBANY, N.Y., May 2, 2012 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced it will issue first quarter financial results before the opening of the market on Wednesday, May 9, 2012. Following the release of its results, the company will host a conference call and simultaneous webcast at 10 a.m. ET. (Logo: http://photos.prnewswire.com/prnh/20120229/NY61160LOGO ) The conference call can be accessed by dialing 888-417-8465 (domestic calls) or 719-325-2361 (international calls) at 9:45 a.m....

2012-04-26 02:28:54

ALBANY, N.Y., April 26, 2012 /PRNewswire/ -- AMRI (NASDAQ: AMRI), a leading global contract research and manufacturing organization, announced today a key addition to the management team at its Singapore location. Saravanakumar Dhakshinamoorthy, Ph.D. joins AMRI's Singapore site as Director of In Vitro Biology, reporting to Takeshi Yura, Ph.D., Senior Director, AMRI Singapore. As the leader of AMRI's biology resources and staff in Singapore, Dr. Dhakshinamoorthy and his team will be working...

2012-03-28 02:24:45

ALBANY, N.Y., March 28, 2012 /PRNewswire/ -- AMRI (NASDAQ: AMRI) announced today that AMRI Senior Vice President, Administration and Chief Financial Officer Mark T. Frost will present at the Needham Healthcare conference on Tuesday, April 3, 2012 at 9:20 a.m. ET. (Logo: http://photos.prnewswire.com/prnh/20120229/NY61160LOGO ) An audio webcast of the corporate presentation will be available to investors and interested parties by accessing the company's website at www.amriglobal.com. This...

2012-02-01 07:00:00

ALBANY, N.Y., Feb. 1, 2012 /PRNewswire/ -- AMRI (NASDAQ: AMRI) announced today that AMRI Senior Vice President, Administration and Chief Financial Officer Mark T. Frost will present at the UBS 22nd Annual Global Healthcare Services Conference on Wednesday, February 8, 2012 at 11:00 a.m. ET. An audio webcast of the corporate presentation will be available to investors and interested parties by accessing the company's website at www.amriglobal.com. A replay of the webcast will be...

2012-01-31 07:00:00

ALBANY, N.Y., Jan. 31, 2012 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced it will issue fourth quarter and full year financial results before the opening of the market on Tuesday, February 7, 2012. Following the release of its results, the company will host a conference call and simultaneous webcast at 10 a.m. ET. The conference call can be accessed by dialing 800-341-3130 (domestic calls) or 913-312-1393 (international calls) at 9:45 a.m. ET and entering passcode 6376884....